SEARCH
Quotes News NAV
Quarterly Results Markets  >  Corporate Information  >   Quarterly Results
Glaxosmithkline Pharmaceuticals Ltd Industry:  Pharmaceuticals - Multinational
BSE Code ISIN Demat Book Value
(R)
NSE
Symbol
Div Yield
%
Market Cap
(Rs.Cr)
P/E
(TTM)
EPS
(TTM)
Face Value
(R)
500660 INE159A01016 91.3566062 GLAXO 1.6 33,866.81 53.28 37.52 10
Quarters :
ParticularsDec 2023(Rs.Cr)Sep 2023(Rs.Cr)Jun 2023(Rs.Cr)
Gross Sales804.98953.38738.02
Other Operating Income0.000.000.00
Other Income 28.3428.4754.10
Total Income833.32981.85792.12
Total Expenditure 750.78666.80596.77
PBIDT82.54315.05195.35
Interest 0.320.430.28
PBDT82.22314.62195.07
Depreciation17.1118.1116.36
Tax31.3290.6052.63
Fringe Benefit Tax0.000.000.00
Deferred Tax-11.70-9.63-4.50
Reported Profit After Tax45.49215.54130.58
Extra-ordinary Items -131.990.0012.21
Adjusted Profit After Extra-ordinary item177.48215.54118.37
    
EPS (Unit Curr.)2.6912.726.94
EPS (Adj) (Unit Curr.)2.6912.726.94
Calculated EPS (Unit Curr.)2.6912.727.71
Calculated EPS (Adj) (Unit Curr.)2.6912.727.71
Calculated EPS (Ann.) (Unit Curr.)10.7450.8930.83
Calculated EPS (Adj) (Ann.) (Unit Curr.)10.7450.8930.83
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.00320.000.00
Equity169.41169.41169.41
Reserve & Surplus0.000.000.00
Face Value10.0010.0010.00
    
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
    
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
    
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
    
PBIDTM(%)10.2533.0526.47
PBDTM(%)10.2133.0026.43
PATM(%)5.6522.6117.69